Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.
Saved in:
| Title: | Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial. |
|---|---|
| Authors: | Fergus KB; Department of Surgery, University of California, San Francisco, CA, USA., Heise RS; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Madlensky L; Department of Medicine, University of California, San Diego, CA, USA., Fiscalini A; Department of Surgery, University of California, San Francisco, CA, USA., Sabacan L; Department of Surgery, University of California, San Francisco, CA, USA., Theiner S; Department of Medicine, Santa Clara Valley Medical Center, San Jose, CA, USA., Kapoor S; Department of Surgery, University of California, San Francisco, CA, USA., Soto IA; Department of Surgery, University of California, San Francisco, CA, USA., Blanco A; Department of Cancer Genetics and Prevention, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Ross K; Department of Cancer Genetics and Prevention, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Goodman-Gruen D; Department of Epidemiology and Biostatistics, University of California, Irvine, CA, USA., Scheuner M; Department of Medicine, University of California, San Francisco, CA, USA., Hu D; Department of Medicine, University of California, San Francisco, CA, USA., Heditsian D; Breast Oncology Program, Breast Science Advocacy Core, University of California, San Francisco, CA, USA., Brain S; Breast Oncology Program, Breast Science Advocacy Core, University of California, San Francisco, CA, USA., Arasu VA; Kaiser Permanente Division of Research, Pleasanton, CA, USA., Kaster A; Sanford Health, Sioux Falls, SD, USA., Chapa L; Doctors Hospital at Renaissance, Edinburg, TX, USA., Olopade OI; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, IL, USA., Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Tice JA; Department of Medicine, University of California, San Francisco, CA, USA., Ziv E; Department of Medicine, University of California, San Francisco, CA, USA., van 't Veer L; Department of Laboratory Medicine, University of California, San Francisco, CA, USA., Esserman LJ; Department of Surgery, University of California, San Francisco, CA, USA., Shieh Y; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. yis4001@med.cornell.edu. |
| Corporate Authors: | Athena/WISDOM Network Collaborators and Advocate Partners |
| Source: | Genome medicine [Genome Med] 2025 Aug 28; Vol. 17 (1), pp. 97. Date of Electronic Publication: 2025 Aug 28. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-994X |
|---|---|
| DOI: | 10.1186/s13073-025-01524-7 |
